RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Korean Translation of the GRADE Series Published in the BMJ, ‘GRADE: Incorporating Considerations of Resources Use into Grading Recommendations’ (A Secondary Publication)

      한글로보기

      https://www.riss.kr/link?id=A107041295

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      This article is the fifth translation of a GRADE series published in the BMJ for incorporating the considerations of resources use into grading recommendations. Clinical recommendations inevitably involve judgments about the allocation of resources us...

      This article is the fifth translation of a GRADE series published in the BMJ for incorporating the considerations of resources use into grading recommendations. Clinical recommendations inevitably involve judgments about the allocation of resources use (costs). Although costs differ from typical healthcare outcomes, such as mortality, morbidity, and quality of life, costs are another potentially important outcome that differs across and within a jurisdiction. A balance sheet is a useful method for determining if the net benefits are worth the incremental costs. Resource use, not just monetary values, should always be presented in an evidence profile. Formal economic modeling may or may not help judge the certainty of the evidence for resource use.

      더보기

      참고문헌 (Reference)

      1 O’Brien B, "Users' guides to the medical literature: essentials of evidence-based clinical practice" AMA Press 621-644, 2002

      2 Montori VM, "Users' guide to detecting misleading claims in clinical research reports" 329 : 1093-1096, 2004

      3 Owens DK, "Interpretation of cost-effectiveness analyses" 13 : 716-717, 1998

      4 Guyatt GH, "Incorporating considerations of resources use into grading recommendations" 336 : 1170-1173, 2008

      5 Friedberg M, "Evaluation of conflict of interest in economic analyses of new drugs used in oncology" 282 : 1453-1457, 1999

      6 Garber AM, "Economic foundations of cost effective analysis" 16 : 1-31, 1997

      7 Altman D, "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial : a randomised placebo-controlled trial" 359 : 1877-1890, 2002

      8 Gold MR, "Costeffectiveness in health and medicine" Oxford University Press 1996

      9 Simon J, "Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie trial" 113 : 144-151, 2006

      10 Luce BR, "Cost-effectiveness in health and medicine" Oxford University Press 176-213, 1996

      1 O’Brien B, "Users' guides to the medical literature: essentials of evidence-based clinical practice" AMA Press 621-644, 2002

      2 Montori VM, "Users' guide to detecting misleading claims in clinical research reports" 329 : 1093-1096, 2004

      3 Owens DK, "Interpretation of cost-effectiveness analyses" 13 : 716-717, 1998

      4 Guyatt GH, "Incorporating considerations of resources use into grading recommendations" 336 : 1170-1173, 2008

      5 Friedberg M, "Evaluation of conflict of interest in economic analyses of new drugs used in oncology" 282 : 1453-1457, 1999

      6 Garber AM, "Economic foundations of cost effective analysis" 16 : 1-31, 1997

      7 Altman D, "Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial : a randomised placebo-controlled trial" 359 : 1877-1890, 2002

      8 Gold MR, "Costeffectiveness in health and medicine" Oxford University Press 1996

      9 Simon J, "Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie trial" 113 : 144-151, 2006

      10 Luce BR, "Cost-effectiveness in health and medicine" Oxford University Press 176-213, 1996

      11 Eddy DM, "Comparing benefits and harms : the balance sheet" 263 : 2493-, 1990

      12 Guyatt G, "Addressing resource allocation issues in recommendations from clinical practice guideline panels : suggestions from an American College of Chest Physicians task force" 129 : 182-187, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 선정 (재인증) KCI등재
      2019-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-10-12 학술지명변경 한글명 : 대한요로생식기감염학회지 -> Urogenital Tract Infection
      외국어명 : The Korean Journal of Urogenital Tract Infection and Inflammation -> Urogenital Tract Infection
      KCI등재후보
      2015-01-01 평가 등재후보학술지 유지 (계속평가) KCI등재후보
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.07 0.07 0.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.04 0.03 0.28 0.04
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼